Definium Therapeutics Balance Sheet (2019-2026) | DFTX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
105.74M140.60M131.70M129.41M116.89M115.30M99.70M249.10M242.40M295.28M271.50M80.40M33.39M19.96M255.30M257.20M
Short-term Investments (Quarter)
129.59M149.60M189.10M153.76M110.90M
Cash & Current Investments (Quarter)
105.74M140.60M131.70M129.41M116.89M115.30M99.70M249.10M242.40M295.28M271.50M209.99M182.99M209.06M409.06M368.10M
Prepaid Assets (Quarter)
3.68M2.75M3.17M1.83M3.91M3.00M2.90M2.39M4.17M3.14M4.56M4.07M7.88M9.26M6.14M6.78M7.73M7.14M
Current Assets (Quarter)
137.22M123.23M109.09M156.51M146.06M132.41M119.79M120.09M103.87M255.47M247.69M299.36M281.62M221.70M189.14M215.85M419.32M380.56M
Non-Current Assets
Long-Term Investments (Quarter)
33.10M54.86M
Goodwill (Quarter)
19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M
Intangibles (Quarter)
6.87M6.09M5.27M4.48M3.69M2.90M2.11M1.32M0.53M
Goodwill & Intangibles (Quarter)
26.79M26.01M25.19M24.40M23.61M22.82M22.03M21.23M20.45M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M
Other Non-Current Assets (Quarter)
0.33M0.30M0.27M0.23M0.22M0.14M0.53M0.49M0.61M0.61M1.17M1.15M0.86M0.81M
Non-Current Assets (Quarter)
26.79M26.01M25.19M24.40M23.94M23.12M22.29M21.46M20.67M20.06M20.45M20.41M20.53M53.62M75.95M21.07M20.78M20.73M
Assets (Quarter)
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M
Payables (Quarter)
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M
Accumulated Expenses (Quarter)
2.29M7.23M2.15M3.19M5.88M1.81M2.82M3.50M11.63M1.62M8.23M3.84M12.83M4.36M14.80M19.03M20.45M7.41M
Other Accumulated Expenses (Quarter)
0.00M0.04M0.23M0.09M0.07M0.09M0.09M0.44M0.36M0.29M0.69M0.31M0.28M0.26M0.46M0.50M0.51M0.60M
Total Current Liabilities (Quarter)
10.41M10.56M7.87M26.04M17.89M24.10M35.12M31.15M32.25M65.27M41.85M33.27M38.85M30.48M37.96M65.42M66.70M81.11M
Non-Current Liabilities
Non-Current Debt (Quarter)
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M
Other Non-Current Liabilities (Quarter)
1.93M1.90M1.28M1.18M1.09M0.99M0.35M0.03M0.01M0.54M0.52M0.50M0.56M
Total Non-Current Liabilities (Quarter)
10.41M7.87M26.04M17.89M24.10M35.12M45.22M46.38M79.46M79.15M105.80M107.28M121.89M
Total Liabilities (Quarter)
-171.63M-164.27M12.34M12.43M9.77M27.31M19.08M25.18M36.11M45.57M46.41M79.47M66.10M57.58M60.70M52.52M79.69M106.32M107.77M122.44M
Shareholder's Equity
Total Debt (Quarter)
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M
Common Equity (Quarter)
171.63M164.27M151.66M136.81M124.50M153.59M150.92M130.34M105.97M95.98M78.13M196.06M202.05M262.19M241.45M222.81M185.40M130.60M332.33M278.85M
Shareholder's Equity (Quarter)
171.63M164.27M151.66M136.81M124.50M153.59M150.92M130.34M105.97M95.98M78.13M196.06M202.05M262.19M241.45M222.81M185.40M130.60M332.33M278.85M
Liabilities and Shareholders Equity (Quarter)
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M
Retained Earnings (Quarter)
1.05M1.00M0.85M0.74M0.63M-219.30M-248.41M-266.30M0.34M-344.60M0.83M0.82M-398.88M-422.20M0.81M-532.20M1.08M0.82M
Treasury Shares (Quarter)
0.64M14.01M2.20M1.08M1.52M1.40M2.62M2.52M2.29M0.79M1.74M1.55M1.37M5.95M5.96M5.79M5.46M8.18M